BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4024727)

  • 1. Expression and regulation of the vaccinia virus thymidine kinase gene in non-permissive cells.
    Franke CA; Roseman NA; Hruby DE
    Virus Res; 1985 Jul; 3(1):13-7. PubMed ID: 4024727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of herpes simplex virus thymidine kinase, mediated by vaccinia virus early promoters.
    Sharif A; Mars M; Dru A; Beaud G
    Res Virol; 1989; 140(2):103-13. PubMed ID: 2547234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of expression of the vaccinia virus thymidine kinase gene.
    Hruby DE; Ball LA
    J Virol; 1981 Nov; 40(2):456-64. PubMed ID: 7321094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon sensitivity of expression of histone H5/H1(0)-vaccinia thymidine kinase fusion genes expressed by recombinant vaccinia viruses is enhanced by shortening the histone sequence.
    Blum D; Degen HJ; Redmann-Müller I; Campos M; Jungwirth C
    Virology; 1993 Oct; 196(2):419-26. PubMed ID: 7690499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the virulence of wild-type thymidine kinase (tk)-deficient and tk+ phenotypes of vaccinia virus recombinants after intranasal inoculation of mice.
    Taylor G; Stott EJ; Wertz G; Ball A
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():125-30. PubMed ID: 1990060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a binding factor that interacts with the sequences upstream of the vaccinia virus thymidine kinase gene.
    Wilson EM; Edbauer C; Hruby DE
    Virus Genes; 1988 Oct; 2(1):31-48. PubMed ID: 3227643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular differences in the molecular mechanisms of vaccinia virus host range restriction.
    Hruby DE; Lynn DL; Condit RC; Kates JR
    J Gen Virol; 1980 Apr; 47(2):485-8. PubMed ID: 6767809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression vector pT7:TKII for the synthesis of authentic biologically active RNA encoding vaccinia virus thymidine kinase.
    Wilson EM; Franke CA; Black ME; Hruby DE
    Gene; 1989 Apr; 77(1):69-78. PubMed ID: 2744489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis.
    Ramsey-Ewing A; Moss B
    Virology; 1995 Feb; 206(2):984-93. PubMed ID: 7856109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide sequence and transcript organization of a region of the vaccinia virus genome which encodes a constitutively expressed gene required for DNA replication.
    Roseman NA; Hruby DE
    J Virol; 1987 May; 61(5):1398-406. PubMed ID: 3033268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of recombinant vaccinia virus: cloning into the thymidine kinase locus.
    Byrd CM; Hruby DE
    Methods Mol Biol; 2004; 269():31-40. PubMed ID: 15114005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping and identification of the vaccinia virus thymidine kinase gene.
    Hruby DE; Ball LA
    J Virol; 1982 Aug; 43(2):403-9. PubMed ID: 6287024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant.
    Puhlmann M; Brown CK; Gnant M; Huang J; Libutti SK; Alexander HR; Bartlett DL
    Cancer Gene Ther; 2000 Jan; 7(1):66-73. PubMed ID: 10678358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of authentic vaccinia virus-specific and inserted viral and cellular genes under control of an early vaccinia virus promoter is regulated post-transcriptionally in interferon-treated chick embryo fibroblasts.
    Degen HJ; Blum D; Grün J; Jungwirth C
    Virology; 1992 May; 188(1):114-21. PubMed ID: 1373550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced steady-state levels of vaccinia virus-specific early mRNAs in interferon-treated chick embryo fibroblasts.
    Grün J; Kroon E; Zöller B; Krempien U; Jungwirth C
    Virology; 1987 May; 158(1):28-33. PubMed ID: 2437697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
    McCart JA; Ward JM; Lee J; Hu Y; Alexander HR; Libutti SK; Moss B; Bartlett DL
    Cancer Res; 2001 Dec; 61(24):8751-7. PubMed ID: 11751395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single amino acid substitution abolishes feedback inhibition of vaccinia virus thymidine kinase.
    Black ME; Hruby DE
    J Biol Chem; 1992 May; 267(14):9743-8. PubMed ID: 1577811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene.
    Ramsey-Ewing AL; Moss B
    Virology; 1996 Aug; 222(1):75-86. PubMed ID: 8806489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-frequency homologous recombination in vaccinia virus DNA.
    Ball LA
    J Virol; 1987 Jun; 61(6):1788-95. PubMed ID: 3573150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA.
    Weir JP; Bajszár G; Moss B
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1210-4. PubMed ID: 6280173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.